» Articles » PMID: 3244637

Dissolution of Ionizable Drugs in Buffered and Unbuffered Solutions

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 1988 May 1
PMID 3244637
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The dissolution kinetics of ionizable drugs (weak acids or bases) are analyzed with a mathematical model derived from the theory of mass transfer with chemical reaction. The model assumes that the overall process is diffusion limited, that all the reactions are reversible and instantaneous, and that dissolution and reaction are limited to the stagnant fluid film adjacent to the solid phase. Dissolution into buffered and unbuffered aqueous solutions are considered separately, with convenient analytical solutions obtained in both cases. In addition, equations for the time to partial and complete dissolution are derived. The dissolution rate is shown to be dependent on the pKa and intrinsic solubility and the medium properties, i.e., pH, buffer capacity, and mass transfer coefficient. Equations of a form analogous to the nonionized case are derived to account explicitly for all these factors, with dissolution rates expressed in terms of the product of a driving force (concentration difference) and resistance (inverse of mass transfer coefficient). The solutions are in an accessible analytical form to calculate the surface pH and subsequently the surface concentrations driving the drug dissolution. Numerical examples to illustrate dissolution into unbuffered and buffered media are presented and the results are shown to be in accord with experimental data taken from the literature.

Citing Articles

Advances in Modeling Approaches for Oral Drug Delivery: Artificial Intelligence, Physiologically-Based Pharmacokinetics, and First-Principles Models.

Arav Y Pharmaceutics. 2024; 16(8).

PMID: 39204323 PMC: 11359797. DOI: 10.3390/pharmaceutics16080978.


Solubility vs Dissolution in Physiological Bicarbonate Buffer.

Claussen F, Al-Gousous J, Salehi N, Garcia M, Amidon G, Langguth P Pharm Res. 2024; 41(5):937-945.

PMID: 38698196 PMC: 11116206. DOI: 10.1007/s11095-024-03702-5.


Mechanistic Modeling of In Vitro Biopharmaceutic Data for a Weak Acid Drug: A Pathway Towards Deriving Fundamental Parameters for Physiologically Based Biopharmaceutic Modeling.

Kowthavarapu V, Charbe N, Gupta C, Iakovleva T, Stillhart C, Parrott N AAPS J. 2024; 26(3):44.

PMID: 38575716 DOI: 10.1208/s12248-024-00912-y.


Lost in modelling and simulation?.

Sugano K ADMET DMPK. 2022; 9(2):75-109.

PMID: 35299768 PMC: 8920108. DOI: 10.5599/admet.923.


Mechanistic PBPK Modelling to Predict the Advantage of the Salt Form of a Drug When Dosed with Acid Reducing Agents.

Chirumamilla S, Banala V, Jamei M, Turner D Pharmaceutics. 2021; 13(8).

PMID: 34452130 PMC: 8398830. DOI: 10.3390/pharmaceutics13081169.


References
1.
Aunins J, Southard M, Myers R, Himmelstein K, Stella V . Dissolution of carboxylic acids. III: The effect of polyionizable buffers. J Pharm Sci. 1985; 74(12):1305-16. DOI: 10.1002/jps.2600741212. View

2.
Higuchi W, PARROTT E, WURSTER D, Higuchi T . Investigation of drug release from solids. II. Theoretical and experimental study of influences of bases and buffers on rates of dissolution of acidic solids. J Am Pharm Assoc Am Pharm Assoc. 1958; 47(5):376-83. View

3.
Mooney K, Mintun M, Himmelstein K, Stella V . Dissolution kinetics of carboxylic acids II: effect of buffers. J Pharm Sci. 1981; 70(1):22-32. DOI: 10.1002/jps.2600700104. View

4.
Dressman J, Fleisher D . Mixing-tank model for predicting dissolution rate control or oral absorption. J Pharm Sci. 1986; 75(2):109-16. DOI: 10.1002/jps.2600750202. View

5.
Mooney K, Mintun M, Himmelstein K, Stella V . Dissolution kinetics of carboxylic acids I: effect of pH under unbuffered conditions. J Pharm Sci. 1981; 70(1):13-22. DOI: 10.1002/jps.2600700103. View